Selected research
Industry Research
Cough Lozenges Industry Research Report 2026
Market perspective
The global Cough Lozenges market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cough Lozenges is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cough Lozenges is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cough Lozenges include Xi'an Keli Pharmaceutical, Sanofi, Novartis, Mylan, Jiuzhitang, Jiangxi Jianglai Health Technology, Pfizer, Hebei Bianque Pharmaceutical and Guizhou Kehui Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cough Lozenges market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cough Lozenges Market by Company
Xi'an Keli Pharmaceutical
Sanofi
Novartis
Mylan
Jiuzhitang
Jiangxi Jianglai Health Technology
Pfizer
Hebei Bianque Pharmaceutical
Guizhou Kehui Pharmaceutical
GlaxoSmithKline
Bayer
Amgen
AbbVie
AstraZeneca
Reckitt Benckiser
Procter And Gamble
Johnson And Johnson
Herbalife
Cigna
Boehringer Ingelheim
Cough Lozenges Segment by Type
Traditional Chinese Medicine Type
Biological Agent Type
Chemical Medicine Type
Compound Preparation Type
Cough Lozenges Segment by Application
Clinic
Hospital
Pharmacy
Retail Store
Others
Cough Lozenges Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cough Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cough Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cough Lozenges.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cough Lozenges manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cough Lozenges by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cough Lozenges in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Traditional Chinese Medicine Type
- Biological Agent Type
- Chemical Medicine Type
- Compound Preparation Type
Applications
- Clinic
- Hospital
- Pharmacy
- Retail Store
- Others
Companies covered
- Xi'an Keli Pharmaceutical
- Sanofi
- Novartis
- Mylan
- Jiuzhitang
- Jiangxi Jianglai Health Technology
- Pfizer
- Hebei Bianque Pharmaceutical
- Guizhou Kehui Pharmaceutical
- GlaxoSmithKline
- Bayer
- Amgen
- AbbVie
- AstraZeneca
- Reckitt Benckiser
- Procter And Gamble
- Johnson And Johnson
- Herbalife
- Cigna
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cough Lozenges Market Size (2021-2032)
- 2.2.2 Global Cough Lozenges Sales (2021-2032)
- 2.2.3 Global Cough Lozenges Market Average Price (2021-2032)
- 2.3 Cough Lozenges by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Traditional Chinese Medicine Type
- 2.3.3 Biological Agent Type
- 2.3.4 Chemical Medicine Type
- 2.3.5 Compound Preparation Type
- 2.4 Cough Lozenges by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Pharmacy
- 2.4.5 Retail Store
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cough Lozenges Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cough Lozenges Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Cough Lozenges Revenue of Manufacturers (2021-2026)
- 3.4 Global Cough Lozenges Average Price by Manufacturers (2021-2026)
- 3.5 Global Cough Lozenges Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cough Lozenges, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cough Lozenges, Product Type & Application
- 3.8 Global Manufacturers of Cough Lozenges, Established Date
- 3.9 Global Cough Lozenges Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Xi'an Keli Pharmaceutical
- 4.1.1 Xi'an Keli Pharmaceutical Company Information
- 4.1.2 Xi'an Keli Pharmaceutical Business Overview
- 4.1.3 Xi'an Keli Pharmaceutical Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Xi'an Keli Pharmaceutical Cough Lozenges Product Portfolio
- 4.1.5 Xi'an Keli Pharmaceutical Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Cough Lozenges Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Cough Lozenges Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Cough Lozenges Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Jiuzhitang
- 4.5.1 Jiuzhitang Company Information
- 4.5.2 Jiuzhitang Business Overview
- 4.5.3 Jiuzhitang Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jiuzhitang Cough Lozenges Product Portfolio
- 4.5.5 Jiuzhitang Recent Developments
- 4.6 Jiangxi Jianglai Health Technology
- 4.6.1 Jiangxi Jianglai Health Technology Company Information
- 4.6.2 Jiangxi Jianglai Health Technology Business Overview
- 4.6.3 Jiangxi Jianglai Health Technology Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangxi Jianglai Health Technology Cough Lozenges Product Portfolio
- 4.6.5 Jiangxi Jianglai Health Technology Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Cough Lozenges Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Hebei Bianque Pharmaceutical
- 4.8.1 Hebei Bianque Pharmaceutical Company Information
- 4.8.2 Hebei Bianque Pharmaceutical Business Overview
- 4.8.3 Hebei Bianque Pharmaceutical Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hebei Bianque Pharmaceutical Cough Lozenges Product Portfolio
- 4.8.5 Hebei Bianque Pharmaceutical Recent Developments
- 4.9 Guizhou Kehui Pharmaceutical
- 4.9.1 Guizhou Kehui Pharmaceutical Company Information
- 4.9.2 Guizhou Kehui Pharmaceutical Business Overview
- 4.9.3 Guizhou Kehui Pharmaceutical Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Guizhou Kehui Pharmaceutical Cough Lozenges Product Portfolio
- 4.9.5 Guizhou Kehui Pharmaceutical Recent Developments
- 4.10 GlaxoSmithKline
- 4.10.1 GlaxoSmithKline Company Information
- 4.10.2 GlaxoSmithKline Business Overview
- 4.10.3 GlaxoSmithKline Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GlaxoSmithKline Cough Lozenges Product Portfolio
- 4.10.5 GlaxoSmithKline Recent Developments
- 4.11 Bayer
- 4.11.1 Bayer Company Information
- 4.11.2 Bayer Business Overview
- 4.11.3 Bayer Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bayer Cough Lozenges Product Portfolio
- 4.11.5 Bayer Recent Developments
- 4.12 Amgen
- 4.12.1 Amgen Company Information
- 4.12.2 Amgen Business Overview
- 4.12.3 Amgen Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Amgen Cough Lozenges Product Portfolio
- 4.12.5 Amgen Recent Developments
- 4.13 AbbVie
- 4.13.1 AbbVie Company Information
- 4.13.2 AbbVie Business Overview
- 4.13.3 AbbVie Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AbbVie Cough Lozenges Product Portfolio
- 4.13.5 AbbVie Recent Developments
- 4.14 AstraZeneca
- 4.14.1 AstraZeneca Company Information
- 4.14.2 AstraZeneca Business Overview
- 4.14.3 AstraZeneca Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 AstraZeneca Cough Lozenges Product Portfolio
- 4.14.5 AstraZeneca Recent Developments
- 4.15 Reckitt Benckiser
- 4.15.1 Reckitt Benckiser Company Information
- 4.15.2 Reckitt Benckiser Business Overview
- 4.15.3 Reckitt Benckiser Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Reckitt Benckiser Cough Lozenges Product Portfolio
- 4.15.5 Reckitt Benckiser Recent Developments
- 4.16 Procter And Gamble
- 4.16.1 Procter And Gamble Company Information
- 4.16.2 Procter And Gamble Business Overview
- 4.16.3 Procter And Gamble Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Procter And Gamble Cough Lozenges Product Portfolio
- 4.16.5 Procter And Gamble Recent Developments
- 4.17 Johnson And Johnson
- 4.17.1 Johnson And Johnson Company Information
- 4.17.2 Johnson And Johnson Business Overview
- 4.17.3 Johnson And Johnson Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Johnson And Johnson Cough Lozenges Product Portfolio
- 4.17.5 Johnson And Johnson Recent Developments
- 4.18 Herbalife
- 4.18.1 Herbalife Company Information
- 4.18.2 Herbalife Business Overview
- 4.18.3 Herbalife Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Herbalife Cough Lozenges Product Portfolio
- 4.18.5 Herbalife Recent Developments
- 4.19 Cigna
- 4.19.1 Cigna Company Information
- 4.19.2 Cigna Business Overview
- 4.19.3 Cigna Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Cigna Cough Lozenges Product Portfolio
- 4.19.5 Cigna Recent Developments
- 4.20 Boehringer Ingelheim
- 4.20.1 Boehringer Ingelheim Company Information
- 4.20.2 Boehringer Ingelheim Business Overview
- 4.20.3 Boehringer Ingelheim Cough Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Boehringer Ingelheim Cough Lozenges Product Portfolio
- 4.20.5 Boehringer Ingelheim Recent Developments
5 Global Cough Lozenges Market Scenario by Region
- 5.1 Global Cough Lozenges Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cough Lozenges Sales by Region: 2021-2032
- 5.2.1 Global Cough Lozenges Sales by Region: 2021-2026
- 5.2.2 Global Cough Lozenges Sales by Region: 2027-2032
- 5.3 Global Cough Lozenges Revenue by Region: 2021-2032
- 5.3.1 Global Cough Lozenges Revenue by Region: 2021-2026
- 5.3.2 Global Cough Lozenges Revenue by Region: 2027-2032
- 5.4 North America Cough Lozenges Market Facts & Figures by Country
- 5.4.1 North America Cough Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cough Lozenges Sales by Country (2021-2032)
- 5.4.3 North America Cough Lozenges Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cough Lozenges Market Facts & Figures by Country
- 5.5.1 Europe Cough Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cough Lozenges Sales by Country (2021-2032)
- 5.5.3 Europe Cough Lozenges Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cough Lozenges Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cough Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cough Lozenges Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cough Lozenges Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cough Lozenges Market Facts & Figures by Country
- 5.7.1 South America Cough Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cough Lozenges Sales by Country (2021-2032)
- 5.7.3 South America Cough Lozenges Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cough Lozenges Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cough Lozenges Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cough Lozenges Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cough Lozenges Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cough Lozenges Sales by Type (2021-2032)
- 6.1.1 Global Cough Lozenges Sales by Type (2021-2032) & (units)
- 6.1.2 Global Cough Lozenges Sales Market Share by Type (2021-2032)
- 6.2 Global Cough Lozenges Revenue by Type (2021-2032)
- 6.2.1 Global Cough Lozenges Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cough Lozenges Revenue Market Share by Type (2021-2032)
- 6.3 Global Cough Lozenges Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cough Lozenges Sales by Application (2021-2032)
- 7.1.1 Global Cough Lozenges Sales by Application (2021-2032) & (units)
- 7.1.2 Global Cough Lozenges Sales Market Share by Application (2021-2032)
- 7.2 Global Cough Lozenges Revenue by Application (2021-2032)
- 7.2.1 Global Cough Lozenges Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cough Lozenges Revenue Market Share by Application (2021-2032)
- 7.3 Global Cough Lozenges Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cough Lozenges Value Chain Analysis
- 8.1.1 Cough Lozenges Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cough Lozenges Production Mode & Process
- 8.2 Cough Lozenges Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cough Lozenges Distributors
- 8.2.3 Cough Lozenges Customers
9 Global Cough Lozenges Analyzing Market Dynamics
- 9.1 Cough Lozenges Industry Trends
- 9.2 Cough Lozenges Industry Drivers
- 9.3 Cough Lozenges Industry Opportunities and Challenges
- 9.4 Cough Lozenges Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst